证券代码：301330 证券简称：熵基科技 公告编号：2025-068 熵基科技股份有限公司 关于注销及开立闲置募集资金现金管理专用结算账户的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完 整，没有虚假记载、误导性陈述或重大遗漏。 根据《上市公司监管指引第 2 号——上市公司募集资金管理和使用的监管要 求》及《深圳证券交易所上市公司自律监管指引第 2 号——创业板上市公司规范 运作》等法律法规的相关规定，上述账户将仅用于闲置募集资金（含超募资金） 进行现金管理的专用结算，不会用于存放非募集资金或用作其他用途。 三、投资风险及风险控制措施 （一）投资风险分析 1、虽然投资产品均经过严格的评估，但金融市场受宏观经济影响，不排除 该项投资受到市场波动的影响。 为提高闲置募集资金使用效率，合理利用暂时闲置的募集资金，增加公司投 资收益和股东回报，熵基科技股份有限公司（以下简称"公司"）于 2024 年 8 月 28 日召开第三届董事会第十一次会议和第三届监事会第十次会议，审议通过 了《关于使用部分暂时闲置募集资金进行现金管理的议案》，同意公司及子公司 使用不超过人民币 80,000 万元（含本数）的部分 ...

7月31日，熵基科技主力资金净流入6031.32万元，占流通市值的2.25%。该股当日开盘价为28.00元，最 高触及29.22元，最低下探至27.88元，振幅为4.76%。 风险提示：市场有风险，投资需谨慎。 来源：金融界 消息面上，国家医保局近期出台政策支持医疗新技术发展，其中脑机接口技术被纳入医疗服务价格项 目。该技术获批进入临床后，可快速进入临床应用并收费。市场认为这将加速脑机接口技术的商业化进 程。 熵基科技7月31日股价报收29.21元，较前一交易日上涨1.07元，涨幅3.80%。当日成交量为172744手， 成交金额达4.95亿元，换手率为18.84%。 熵基科技属于软件开发行业，公司主营业务涉及物联网、国家安防等领域。公司注册地位于广东省，是 融资融券标的之一。 ...

天眼查商业履历信息显示，熵基科技股份有限公司，成立于2007年，位于东莞市，是一家以从事计算 机、通信和其他电子设备制造业为主的企业。企业注册资本23535.155万人民币，实缴资本19631.2325万 人民币。公司法定代表人为金海荣。 通过天眼查大数据分析，熵基科技股份有限公司共对外投资了16家企业，参与招投标项目1424次，知识 产权方面有商标信息928条，专利信息1172条，此外企业还拥有行政许可21个。 来源：金融界 金融界消息 截至2025年7月31日收盘，熵基科技（301330）报收于29.21元，上涨3.8%，换手率 18.84%，成交量17.27万手，成交金额4.95亿元。 资金流向方面，今日主力资金净流入6031.32万元，占比成交额12.2%。其中，超大单净流入3336.02万 元、占成交额6.75%，大单净流入2695.29万元、占成交额5.45%，中单净流出流出432.52万元、占成交 额0.87%，小单净流出5598.80万元、占成交额11.32%。 熵基科技最新一期业绩显示，截至2025一季报，公司营业总收入4.14亿元、同比增长3.50%，归属净利 润2946.27万元，同比增 ...

7月31日，人脑工程概念上涨0.27%，今日主力资金流入7729.22万元，概念股14只上涨，19只下跌。 主力资金净流入居前的分别为科大讯飞（2.28亿元）、创新医疗（9399.58万元）、乐普医疗（6230.96 万元）、熵基科技（6031.32万元）、爱朋医疗（3162.54万元）。 来源：金融界 序号代码名称最新价涨跌幅主力净流入主力净占比1002230科大讯飞48.780.762.28亿元8.28%2002173创 新医疗15.347.729399.58万元8.27%3300003乐普医疗15.560.846230.96万元5.49%4301330熵基科技 29.213.86031.32万元12.2%5300753爱朋医疗31.397.283162.54万元5.27%6002195岩山科技5.741.232957.49 万元1.87%7301293三博脑科50.083.582790.86万元3.88%8603610麒盛科技12.662.592028.90万元 9.16%9300678中科信息33.980.651515.56万元3.66%10688273麦澜德33.76-0.591193.99万元9. ...

消息面上，为支持药品和医疗器械创新发展，国家医保局制定新上市药品首发价格机制，新增了100多 项与医疗新技术相关的价格项目。神经系统类立项指南统一设立"脑机接口置入费""脑机接口适配费"等 价格项目，脑机接口技术成熟获批进入临床后，可快速进入临床应用并收费。耳鼻喉类立项指南统一设 立"人工耳蜗植入费""发音装置安装费"等价格项目，鼓励医疗机构帮助更多患者"听得见、说得出"。放 射治疗类立项指南统一设立"质子放疗""重离子放疗"等价格项目，促进高端医疗设备的临床转化应用。 与此同时，为鼓励药品研发创新，国家医保局还制定了新上市药品首发价格机制。 格隆汇7月31日｜脑机接口概念股拉升，其中，创新医疗逼近涨停，爱朋医疗、三博脑科、熵基科技、 麒盛科技、岩山科技等跟涨。 ...

消息面上，为支持药品和医疗器械创新发展，国家医保局制定新上市药品首发价格机制，新增了100多 项与医疗新技术相关的价格项目。神经系统类立项指南统一设立"脑机接口置入费""脑机接口适配费"等 价格项目，脑机接口技术成熟获批进入临床后，可快速进入临床应用并收费。耳鼻喉类立项指南统一设 立"人工耳蜗植入费""发音装置安装费"等价格项目，鼓励医疗机构帮助更多患者"听得见、说得出"。放 射治疗类立项指南统一设立"质子放疗""重离子放疗"等价格项目，促进高端医疗设备的临床转化应用。 与此同时，为鼓励药品研发创新，国家医保局还制定了新上市药品首发价格机制。 格隆汇7月31日｜脑机接口概念股拉升，其中，创新医疗逼近涨停，爱朋医疗、三博脑科、熵基科技、 麒盛科技、岩山科技等跟涨。 ...

证券代码：301330 证券简称：熵基科技 公告编号：2025-067 熵基科技股份有限公司 关于注销及开立闲置募集资金现金管理专用结算账户的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完 整，没有虚假记载、误导性陈述或重大遗漏。 为提高闲置募集资金使用效率，合理利用暂时闲置的募集资金，增加公司投 资收益和股东回报，熵基科技股份有限公司（以下简称"公司"）于 2024 年 8 月 28 日召开第三届董事会第十一次会议和第三届监事会第十次会议，审议通过 了《关于使用部分暂时闲置募集资金进行现金管理的议案》，同意公司及子公司 使用不超过人民币 80,000 万元（含本数）的部分暂时闲置募集资金（含超募资 金）进行现金管理，该使用额度及授权的有效期自公司董事会审议通过之日起 12 个月内有效，并在上述额度内滚动使用。具体内容详见公司于 2024 年 8 月 30 日 在巨潮资讯网（http://www.cninfo.com.cn）披露的《关于使用部分暂时闲置募集 资金进行现金管理的公告》（公告编号：2024-040）。 一、注销闲置募集资金现金管理专用结算账户的情况 因购买理财产品的需要，公司在招商银 ...

Group 1 - The unmanned retail concept declined by 1.34%, ranking among the top declines in the concept sector, with notable declines in companies like Huijin Co., Shanjike Technology, and Shen Si Electronics [1][2] - Among the unmanned retail sector, 24 stocks experienced net outflows of main funds totaling 319 million yuan, with Huijin Co. leading the outflow at 168 million yuan [2][3] - The top gainers in the unmanned retail sector included Gongxiao Daji, Xinbeiyang, and Hongqi Lianchuan, with increases of 2.59%, 1.92%, and 1.28% respectively [1][2] Group 2 - The main funds saw a net inflow in stocks like Gongxiao Daji and Xin Kaipu, with inflows of 126 million yuan and 16.43 million yuan respectively [2][3] - The top stocks with significant net outflows included Huijin Co. (-17.70%), Kela Software (-2.48%), and Newland (-0.15%) [2][3] - The overall market sentiment reflected a mixed performance across various concept sectors, with silicon energy leading gains at 3.39% while the unmanned retail sector faced notable declines [2]

Group 1 - *ST San Sheng (002742.SZ): The controlling shareholder Pan Xianwen's 32.2 million shares have been transferred, accounting for 7.30% of the total share capital, reducing his holding from 17.26% to 16.75, with no change in company control [1] - Aikang Co., Ltd. (300889.SZ): Shareholders Zhang Fengbin and Feng Renrong reduced their holdings by a total of 1.76 million shares, accounting for 1.06% of the total share capital, completing the reduction plan [1] - Allianz Ruishi (301042.SZ): Director Shen Lei reduced his holdings by 98,700 shares, accounting for 0.14% of the total share capital, with the reduction plan period ending [1] Group 2 - Baotong Technology (300031.SZ): Controlling shareholder Bao Zhifang and director Tang Yu plan to reduce their holdings by up to 8.3749 million shares and 1.526988 million shares, accounting for no more than 2% and 0.36% of the total share capital, respectively [2] - Biyiwei (688045.SH): Shareholders Fang Guang Erqi and Yuan Chengjun plan to reduce their holdings by up to 139,680 shares and 69,840 shares, accounting for no more than 2% and 1% of the total share capital, respectively [2] - Chahua Co., Ltd. (603615.SH): Shareholder Shenzhen Hanjinliang reduced 2.397 million shares, accounting for 0.99% of the total share capital, completing the reduction plan [2] Group 3 - Dacai Co., Ltd. (605287.SH): Shareholder Qingdao Dikuang Chanquan Development Co., Ltd. reduced 3.64 million shares, accounting for 2.60% of the total share capital, completing the reduction plan [3] - Dize Pharmaceutical (688192.SH): Vice President Zhang Shiying reduced 161,550 shares, accounting for 0.0035% of the total share capital, completing the reduction plan [3] - Fuhan Micro (300613.SZ): Controlling shareholder's concerted action party plans to reduce up to 6.90208 million shares, accounting for 3% of the total share capital [3] Group 4 - Guanghuan Xinwang (300383.SZ): Directors and vice presidents plan to reduce a total of up to 720,476 shares, accounting for no more than 0.04% of the total share capital [4] - Hanyu Group (300403.SZ): Director and Vice President Wu Geming plans to reduce up to 1 million shares, accounting for 0.1658% of the total share capital [4] - Haosen Intelligent (688529.SH): Shareholders plan to reduce a total of up to 3 million shares, accounting for 1.7838% of the total share capital [4] Group 5 - Huilong New Materials (301057.SZ): Controlling shareholder's concerted action party plans to reduce up to 3.482902 million shares, accounting for 3% of the total share capital excluding repurchased shares [5] - Huitong Co., Ltd. (688219.SH): Shareholder Tong'an Fund reduced 4.667815 million shares, accounting for 0.93% of the total share capital, completing the reduction plan [5] Group 6 - Jiangsu Shentong (002438.SZ): Shareholder Huzhou Fenglin Huoshan Equity Investment Partnership reduced a total of 14.205 million shares, accounting for 2.798808% of the total share capital, completing the reduction plan [6] - Jiangtian Chemical (300927.SZ): Shareholder Jiangshan Co., Ltd. reduced 1.3265 million shares, accounting for 0.92% of the total share capital [6] - Jin Sanjiang (301059.SZ): Shareholder Guangzhou Saina reduced 104,900 shares, accounting for 0.05% of the total share capital, completing the reduction plan [6] Group 7 - Jingxue Energy (301010.SZ): Controlling shareholder's concerted action party reduced 1.08 million shares, accounting for 1% of the total share capital, completing the reduction plan [7] - Jiuwu High-Tech (300631.SZ): Vice President Wang Xiaohu and Cheng Junjun plan to reduce up to 18,900 shares and 5,000 shares, accounting for no more than 0.1511% and 0.04% of the total share capital, respectively [7] - Kanghui Pharmaceutical (603139.SH): Shareholder Shanghai Sailoxian plans to reduce up to 2.9964 million shares, accounting for 3% of the total share capital [7] Group 8 - Meino Biological (301156.SZ): Shareholder's concerted action party reduced 1.297029 million shares, accounting for 0.92% of the total share capital, completing the reduction plan [8] - Minfa Aluminum Industry (002578.SZ): Shareholder Huang Tianhuo reduced 6.6702 million shares, accounting for 0.71% of the total share capital, reducing his holding to 4.9963% [8] - Nuo Puxin (002215.SZ): Directors and senior management plan to reduce a total of up to 1.8607 million shares, accounting for no more than 0.185% of the total share capital [8] Group 9 - Entropy Technology (301330.SZ): Shareholders reduced a total of 4,693,864 shares, accounting for 1.9556% of the total share capital, completing the reduction plan [9] - Shengbang Co., Ltd. (301233.SZ): Supervisor Hu Jilin plans to reduce up to 5,650 shares, accounting for 0.0111% of the total share capital [9] - Shudao Equipment (300540.SZ): Senior management did not reduce their shares, and the reduction plan period has ended [9] Group 10 - Tongyu Communications (002792.SZ): Controlling shareholder and actual controller Shi Guiqing plans to reduce up to 15,653,487 shares, accounting for 2.9963% of the total share capital [10] Group 11 - Wuzhou Xinchun (603667.SH): Senior management plans to reduce a total of up to 22,500 shares, accounting for no more than 0.0061%, 0.0067%, and 0.0037% of the total share capital [11] - New Sharp Co., Ltd. (688257.SH): Senior management plans to reduce up to 750,000 shares, accounting for no more than 0.2971% of the total share capital [11] - New Hope (000876.SZ): Senior management reduced 225,000 shares, accounting for 0.005% of the total share capital, completing the reduction plan [11] Group 12 - Youke De (688158.SH): Shareholder Zhongyi Capital reduced 882,766 shares, accounting for 0.19% of the total share capital, completing the reduction plan [12] - Changqing Technology (001324.SZ): Shareholders reduced a total of 4,165,050 shares, accounting for 3.00% of the total share capital, completing the reduction plan [12] - Changxin Bochuang (300548.SZ): Shareholders plan to reduce up to 8.6 million shares, accounting for 2.95% of the total share capital [12] Group 13 - Zhongfu Industrial (600595.SH): Shareholder Henan Yicheng Chuangtou plans to reduce up to 40 million shares, accounting for 1% of the total share capital [13] - Zhuhai Ming Technology (300232.SZ): Controlling shareholder Lin Mingfeng plans to reduce up to 21,722,009 shares, accounting for 1.99% of the total share capital [13] - Zhuoyi Information (688258.SH): Employee shareholding platform plans to reduce up to 2,271,445 shares, accounting for no more than 1.88% of the total share capital [13]

证券代码：301330 证券简称：熵基科技 公告编号：2025-066 熵基科技股份有限公司 关于持股 5%以上股东减持计划期限届满的公告 股东深圳精英士君投资企业（有限合伙）及深圳精英和义投资企 业（有限合伙）保证向本公司提供的信息内容真实、准确、完整，没 有虚假记载、误导性陈述或重大遗漏。 本公司及董事会全体成员保证公告内容与信息披露义务人提供 的信息一致。 熵基科技股份有限公司（以下简称"公司"或"熵基科技"）于 2025 年 3 月 17 日在巨潮资讯网（www.cninfo.com.cn）披露了《关于持股 5%以上股东减持股 份计划预披露公告》，公司持股 5%以上的股东深圳精英士君投资企业（有限合 伙）（以下简称"精英士君"）及深圳精英和义投资企业（有限合伙）（以下简 称"精英和义"）计划自减持计划预披露公告之日起十五个交易日后的三个月内， 分别以集中竞价和/或大宗交易方式减持公司股份不超过 2,886,600 股（不超过公 司剔除回购专用账户中股份数量后总股本的 1.4873%）。本次减持计划实施前， 精英士君持有公司股份 14,038,400 股，占公司总股本的 7.1511%；精英和义持有 公 ...